Skip to main content

Zirconium (<sup>89</sup> Zr) Girentuximab Senvedoxam

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2768427-84-3
Known Aliases (4)
Common Name
zirconium (89Zr) girentuximab senvedoxam [INN] Zirconium Girentuximab Senvedoxam Zr-89 Zirconium Zr 89 girentuximab deferoxamine
Scientific Name
Immunoglobulin G1, anti-(human antigen MN) (human-Mus musculus monoclonal cG250 γ1-chain), disulfide with human-Mus musculus monoclonal cG250 κ-chain, dimer, N6-[[11,22,33-tri(hydroxy-κO)-12,23,34-tri(oxo-κO)-1,4,15,26-tetraoxo-5,11,16,22,27,33-hexaazapentatriacont-1-yl]oxy]-L-lysine, complex with zirconium-89Zr
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) 9C40S99DV7 Zirconium (<sup>89</sup> Zr) Girentuximab Senvedoxam CAS: 2768427-84-3
INN: 12714
SMS_ID: 300000056150
FDA UNII: 9C40S99DV7
NCI_THESAURUS: C207021
Record Info
IDTJpPe9LzEdwc9ndiXMS3ap
CreatedApril 10, 2026, 9:45 p.m.
ModifiedApril 10, 2026, 11:04 p.m.
Data SourceFDA Substance Registry (openFDA)